Close MenuClose
Close Menu
faculty development

Update on Chronic Refractory Cough

Description

Join us in-person or virtually as we explore the following: -

  • Discussion around issues with current diagnostic approaches to chronic cough.
  • Review of medication approved by FDA for chronic cough.
  • Sensitization of central and peripheral nervous system pertaining to chronic cough.
  • Novel molecular target for the treatment of cough.
  • Current pharmacologic medications undergoing clinical trials and registered on clinicaltrials.gov.

Designed for

Health Professionals in the Creighton Community

When and where

12-1 p.m. CDT, 10-11 a.m. MST, October 12th

Virtual and In-person

Available on Zoom

Provided by

  • Creighton University School of Medicine

Speakers

Kaiser G. Lim, MD

Dr. Kaiser Lim is Medical Co-director in the Pulmonary Function Laboratory at Mayo Clinic Rochester. He is also a consultant in Pulmonary Medicine in the Division of Pulmonary and Critical Care at Mayo, with joint appointments in Allergy and Immunology and Pediatric Allergy. He is an Associate Professor of Medicine and board certified in Internal Medicine, Pulmonary and Critical Care Medicine, and Allergy and Immunology. He completed Internal Medicine Residency at the Cleveland Clinic Foundation in Ohio and his post-fellowship in Eosinophil Immunobiology at Boston University Medical Center.

Dr. Lim's responsibilities at Mayo, over the past 23 years, have included directorship of the asthma clinic for 12 years, founding director of the chronic cough clinic, and directorship of the pulmonary inpatient practice for 6 years. His research interests include asthma, COPD, cough, pulmonary physiology and quality improvement in clinical practice. He is married to a neurologist and has three children.

Date and Time

to
Add to Calendar 20221010T120000Z 20221010T130000Z America/Chicago Update on Chronic Refractory Cough <p>Join us in-person or virtually as we explore the following: -</p> <ul> <li>Discussion around issues with current diagnostic approaches to chronic cough.</li> <li>Review of medication approved by FDA for chronic cough.</li> <li>Sensitization of central and peripheral nervous system pertaining to chronic cough.</li> <li>Novel molecular target for the treatment of cough.</li> <li>Current pharmacologic medications undergoing clinical trials and registered on clinicaltrials.gov.</li> </ul> <h2>Designed for</h2> <p>Health Professionals in the Creighton Community</p> <h2>When and where</h2> <p>12-1 p.m. CDT, 10-11 a.m. MST, October 12th</p> <p>Virtual and In-person</p> <p><a href="https://creighton.zoom.us/s/91030031378" target="_blank">Available on Zoom</a></p> <h2>Provided by</h2> <ul> <li>Creighton University School of Medicine</li> </ul> <h2>Speakers</h2> <p><strong>Kaiser G. Lim, MD</strong></p> <p>Dr. Kaiser Lim is Medical Co-director in the Pulmonary Function Laboratory at Mayo Clinic Rochester. He is also a consultant in Pulmonary Medicine in the Division of Pulmonary and Critical Care at Mayo, with joint appointments in Allergy and Immunology and Pediatric Allergy. He is an Associate Professor of Medicine and board certified in Internal Medicine, Pulmonary and Critical Care Medicine, and Allergy and Immunology. He completed Internal Medicine Residency at the Cleveland Clinic Foundation in Ohio and his post-fellowship in Eosinophil Immunobiology at Boston University Medical Center.</p> <p>Dr. Lim's responsibilities at Mayo, over the past 23 years, have included directorship of the asthma clinic for 12 years, founding director of the chronic cough clinic, and directorship of the pulmonary inpatient practice for 6 years. His research interests include asthma, COPD, cough, pulmonary physiology and quality improvement in clinical practice. He is married to a neurologist and has three children.</p> Creighton University Medical Center - Bergan Mercy 1st Floor #11661A/B/C Omaha, Nebraska

Location

Creighton University Medical Center - Bergan Mercy
1st Floor #11661A/B/C
Omaha, Nebraska
Tags:
Close SidebarClose Sidebar